Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer.

A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer. Br J Cancer. 2012 Aug 07; 107(4):695-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.